Lusong Luo
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Cancer Mechanisms and Therapy
- Lymphoma Diagnosis and Treatment
Papers in
-
- Hedgehog Signaling Pathway Studies 7
- Melanoma and MAPK Pathways 5
- PI3K/AKT/mTOR signaling in cancer 5
- Oncology 29
- Cancer-related Molecular Pathways 7
- Co-authors
- Robert A. Copeland (10 shared papers)Peter J. Tummino (8 shared papers)David B. Solit (1 shared paper)Yijun Gao (1 shared paper)Zhan Yao (2 shared papers)Elisa de Stanchina (1 shared paper)Neilawattie M. Torres (1 shared paper)Omar Abdel‐Wahab (1 shared paper)
- Journals
- Cancer Research (12 papers)European Journal of Medicinal Chemistry (8 papers)Biochemistry (4 papers)Analytical Biochemistry (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lusong Luo
48 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 91
- Genetics 228
- Pathology and Forensic Medicine 337
- Oncology 480
- Cancer Research 209
- Cell Biology 225
Countries citing papers authored by Lusong Luo
This map shows the geographic impact of Lusong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lusong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lusong Luo more than expected).
Fields of papers citing papers by Lusong Luo
This network shows the impact of papers produced by Lusong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lusong Luo. The network helps show where Lusong Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lusong Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 358 | |
| 2 | 2011 | 135 | |
| 3 | 2007 | 100 | |
| 4 | 2008 | 98 | |
| 5 | 2015 | 96 | |
| 6 | 2007 | 92 | |
| 7 | 2017 | 69 | |
| 8 | 2004 | 43 | |
| 9 | 2015 | 41 | |
| 10 | 2007 | 38 | |
| 11 | 2015 | 35 | |
| 12 | 2011 | 33 | |
| 13 | 2006 | 29 | |
| 14 | 2018 | 24 | |
| 15 | 2014 | 20 | |
| 16 | 2017 | 19 | |
| 17 | 2015 | 17 | |
| 18 | 2016 | 17 | |
| 19 | 2015 | 17 | |
| 20 | 2020 | 17 |
About Lusong Luo
Lusong Luo is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Genetics and Cell Biology, having authored 48 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Cancer-related Molecular Pathways (7 papers), Hedgehog Signaling Pathway Studies (7 papers), Melanoma and MAPK Pathways (5 papers), Microtubule and mitosis dynamics (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Genetics (228 citations), Pathology and Forensic Medicine (337 citations), Oncology (480 citations), Cancer Research (209 citations) and Cell Biology (225 citations). Lusong Luo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Robert A. Copeland, Peter J. Tummino, David B. Solit, Yijun Gao, Zhan Yao, Elisa de Stanchina, Neilawattie M. Torres, Omar Abdel‐Wahab, Poulikos I. Poulikakos and Anthony Tao. Their work appears in journals such as Cancer Research, European Journal of Medicinal Chemistry, Biochemistry, Analytical Biochemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.